Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Reexamination Certificate
2007-02-27
2007-02-27
Smith, Lynette R. F. (Department: 1645)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
C423S374000, C423S405000, C424S093450, C424S152100, C424S153100, C424S157100, C424S178100, C424S278100, C435S003000, C435S069510, C435S069520, C435S069600, C435S252900, C435S335000, C435S337000, C435S340000, C435S343000, C435S375000, C436S009000, C436S106000, C436S116000, C436S543000, C436S815000, C530S351000, C530S365000, C530S380000, C530S388230, C530S388700, C530S388730, C530S389200
Reexamination Certificate
active
09856969
ABSTRACT:
The invention concerns lactic acid bacteria strains capable of regulating the production of NO and inflammatory cytokines by enterocytes, depending on the inflammatory condition of said enterocytes. The strains can also be incorporated in food supplements such as fermented dairy products used for regulating inflammatory response and non-specific immunity.
REFERENCES:
patent: 5032399 (1991-07-01), Gorbach et al.
patent: 5413785 (1995-05-01), Nanji
patent: 5591428 (1997-01-01), Bengmark et al.
patent: 5716615 (1998-02-01), Cavaliere Vesely et al.
patent: 6399055 (2002-06-01), Postaire et al.
patent: 6444203 (2002-09-01), Krueger et al.
patent: 2126071 (1992-09-01), None
patent: WO 88/ 00438 (1988-01-01), None
patent: 0 199 535 (1996-10-01), None
patent: 0 794 707 (1997-09-01), None
patent: 0 861 905 (1998-09-01), None
patent: WO 96/20607 (1996-06-01), None
patent: WO 96/20607 (1996-07-01), None
patent: WO 98/06411 (1998-02-01), None
patent: WO 98/27991 (1998-07-01), None
Thomas Witthölf, Lars Eckmann, Jung Mogg Kim, Martin F. Kagnoff;Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells; American Journal of Physiology: Gastrointestinal and Liver Physiology; American Physiological Society; Sep. 1998; pp. G564-G571; vol. 38, No. 3; XP-002115076; Washington, DC, US.
Eric Postaire, Bernard Dugas, Chantal Cayuela, Purificacion Relano, Nathalie Dugas;Role of Nitric Oxide in the Muscosal Immuno-Regulatory Properties of Probiotic Strains; FASEB Journal for Experimental Biology; Mar. 12, 1999; p. A291; vol. 13, No. 4; XP002137007; Bethesda, MD, US.
Tuomola et al., “Adhesion of some probiotic and dairyLactobacillusstrains to Caco-2 cells cultures”,International Journal of Food Microbiology, 41 (1998) pp. 45-51.
Yeung et al., “Species-Specific Indentification of Commercial Probiotic Strains”,American Diary Science Association, vol. 85, No. 5, 2002, pp. 1039-1051.
Majamaa et al., “Lactic Acid Bacterial in the Treatment of Acute Rotavirus Gastroenteritis”,Journal of Pediatric Gastroenterology and Nutrition, 1995, pp. 333-338.
Miettinen et al., “Production of Human Tumor Necrosis Factor Alpha, Interleukin-6, and interleukin-10 is Induced by Lactic Acid Bacteria”,Infection and Immunity, American Society for Microbiology, Dec. 1996. pp. 5403-5405.
Collins, et al., “Deoxyribonucleic Acid Homology Studies ofLactobacillus casei, Lactobacillus paracaseisp. Nov., subsp.Paracaseiand subsp.tolerans, andLactobacillius rhamnousussp. Nov., comb. Nov.”International Journal of Systematic Bacteriology, Apr. 1989, pp. 105-108.
Kaila et al., “Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhea”,Archives of Disease in Childhood, 1995, pp. 51-53.
Perdigon et al., “Immunoadjuvant activity of oralLactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections”,Journal of Dairy Research(1991), pp. 485-496.
Shibolet, et al., “Variable Response to Probiotics in Two Models of Experimental Colitis in Rats”,Inflammatory Bowel Diseases, 2002, pp. 399-406.
VSL #3 product information, www.vslpharma.com.
Isolauri et al., “Oral Bacteriotherapy for Viral Gastroenteritis”,Digestive Diseases and Sciences, vol. 39. No. 12 (Dec. 1994), pp. 2595-2600.
Majamaa et al., “Probiotics: A novel approach in the mangagement of food allergy”,J. Allergy Clin. Immunol, vol. 99, No. 2, 179-185.
Biller, et al., “Treatment of RecurrentClostridium difficileColitis WithLactobacillusGG”,Journal of Pediatric Gastroenterology and Nutrition, 1995, 224-226.
Malin et al., “Promotion of IgA Immune Response in Patients with Crohn's Disease by Oral Bacteriotherapy withLactobacillusGG”,Ann Nutr Metab., 1996, pp. 137-145.
Pelto et al., “Probiotic bacterial down-regulate the mild-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects”,Clinical and Experimental Allergy, 1998, vol. 28, pp. 1474-1479.
Korhonen et al., “Induction of Nitric Oxide Synthesis by ProbioticLactobacillus rhamnosusGG in J774 Macrophages and Human T84 Intestinal Epithelial Cells”,Inflammation, vol 25. No. 4, Aug. 2001, pp. 223-232.
Isolauri et al., “Probiotics: effects on immunity”,Am J Clin Nutr, 2001, 73 (suppl) pp. 444S-450S.
Blacklow et al., “Viral Gastroenterits Agents”,Viruses, Rickettsiae, and Chlamydiae, pp. 805-812.
Dugas et al., “Regulation by Endogenous Interleukin-10 of the Expression of Nitric Oxide Synthase Induced After Ligation of CD23 in Human Macrophages”,Cytokine, vol. 10, No. 9 Sep. 1998, pp. 680-689.
Rachimilewitz et al., “Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease”,NO generation for IBD, 1995, pp. 718-723.
Rachmilewitz et al., “Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity”,Gut, 1995, 37, pp. 247-255.
Kolios et al., “Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines”,Gut, 1998, 43, pp. 56-63.
Alvarez et al., “Immune system stimulation by probiotics”,J Dairy Sci., Jul. 1995, 78(7), pp. 1597-1606.
Perdigon et al., “Systemic augmentation of the immune response in mice by feeding fermented milks withLactobacillus casei and Lactobacillus acidophilus”, Immunology, 1988, 63, pp. 17-23.
Tejada-Simon et al., “Ex Vivo Effects ofLactobacilli, Streptococci, and BifidobacteriaIngestion on Cytokine and Nitric Oxide Production in a Murine Model”,Journal of food Protection, vol. 62, No. 2, 1999, pp. 162-169.
Alican et al., “A critical role for nitric oxide in intestinal barrier function and dysfunction”,American Physiological Society, 1996, pp. G225-G237.
Tepperman et al., “Nitric Oxide Synthase Activity, Viability and Cyclic GMP Levels in Rat Colonic Epithelial Cells: Effect of Endotoxin Challege”,The Journal of Pharmacology and Experimental Therapeutics, vol. 271, No. 3, 1994, pp. 1477-1482.
Korpela et al., “Lactobacillus rhamnosus GG shows antioxidative properties in vascular endothelial cell culture”,Milchwissenschaft, 52(9), 1997, pp. 503-505.
Denariaz et al., “Immunity and Probiotics”, entire manual, 1999.
Dugas et al., “Immunity and Probiotics”,Trends Immunology Today, Sep. 1999, vol. 20 No. 9, pp. 1-4.
Isolauri, Erika, “Promotion of IgA Immune Response in Patients with Crohn's Disease by Oral Bacteriotherapy withLactobacillusGG”,Ann Nutr Metab, 1996, 40, pp. 137-145.
Isolauri, et al., “A HumanLactobacillusStrain (Lactobacillus Caseisp strain GG) Promotes Recovery From Acute Diarrhea in Children”,Pediatrics, vol 88. No. 1, Jul. 1991, pp. 90-97.
Dugas et al., “Nitric oxide production by human monocytes: evidence for a role of CD23”,Immunology Today, vol. 16, No. 12, 1995, pp. 574-580.
Danone World Newsletter, Oct. 1995.
Solis Pereyra et al., “Induction of Human Cytokines By Bacteria Used in Dairy Foods”,Nutrition Research, vol. 13, 1993, pp. 1127-1140.
EP Communication for Application No. 00909291.7.
Cayuela Chantal
Dugas Nathalie
Postaire Eric
Alston & Bird LLP
Compagnie Gervais Danone
Hines J.
Smith Lynette R. F.
LandOfFree
Selection and uses of lactic acid bacteria strains... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selection and uses of lactic acid bacteria strains..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selection and uses of lactic acid bacteria strains... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3843928